Human Vaccines Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Oct 2020| TMR2185A| Transparency

Report Highlights

Global Human Vaccine Market - Scope of Report

TMR’s report on the global human vaccine market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2019 to 2027. The report provides revenue of the global human vaccine market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global human vaccine market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global human vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global human vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global human vaccine market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global human vaccine market.

The report delves into the competitive landscape of the global human vaccine market. Key players operating in the global human vaccine market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global human vaccine market that have been profiled in this report.

Key Questions Answered in Global Human vaccine Market Report

  • What is the scope of growth of product companies in the global human vaccine market?
  • What will be the Y-o-Y growth of the global human vaccine market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global human vaccine market?
  • Will North America continue to be the most profitable market for human vaccine providers?
  • Which factors are anticipated to hamper the growth of the global human vaccine market during the forecast period?
  • Which are the leading companies in the global human vaccine market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global human vaccine market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global human vaccine market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the human vaccine market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the human vaccine market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global human vaccine market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global human vaccine market more reliably and accurately.

Regional Segmentation of Human vaccine Market

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Global Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019-2027
  • Table 2 : Global Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 3 : Global Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019-2027
  • Table 4 : Global Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019-2027
  • Table 5 : Global Human Vaccines Market Size (US$ Mn) Forecast, by Region, 2019-2027
  • Table 6 : Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 7 : Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 8 : Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019-2027
  • Table 9 : Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019-2027
  • Table 10 : Asia Pacific Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019-2027
  • Table 11 : North America Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 12 : North America Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 13 : North America Human Vaccines Market Size (US$) Forecast, by Vaccine Type, 2019-2027
  • Table 14 : North America Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019-2027
  • Table 15 : North America Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019-2027
  • Table 16 : Europe Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 17 : Europe Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 18 : Europe Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019-2027
  • Table 19 : Europe Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019-2027
  • Table 20 : Europe Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019-2027
  • Table 21 : Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 22 : Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 23 : Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019-2027
  • Table 24 : Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019-2027
  • Table 25 : Latin America Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019-2027
  • Table 26 : MEA Human Vaccines Market Size (US$ Mn) Forecast, by Country, 2019-2027
  • Table 27 : MEA Human Vaccines Market Size (US$ Mn) Forecast, by Product, 2019-2027
  • Table 28 : MEA Human Vaccines Market Size (US$ Mn) Forecast, by Vaccine Type, 2019-2027
  • Table 29 : MEA Human Vaccines Market Size (US$ Mn) Forecast, by Age Group, 2019-2027
  • Table 30 : MEA Human Vaccines Market Size (US$ Mn) Forecast, by Distribution Channel, 2019-2027
  • Figure 1 : Global Human Vaccines Market Value Share Analysis, by Vaccine Type, 2018 and 2027
  • Figure 2 : Global Conjugate Market Revenue (US$ Mn), 2017-2027
  • Figure 3 : Global Recombinant Market Revenue (US$ Mn), 2017-2027
  • Figure 4 : Global Inactivated Market Revenue (US$ Mn), 2017-2027
  • Figure 5 : Global Combination Market Revenue (US$ Mn), 2017-2027
  • Figure 6 : Global Attenuated Market Revenue (US$ Mn), 2017-2027
  • Figure 7 : Global Others Market Revenue (US$ Mn), 2017-2027
  • Figure 8 : Human Vaccines Market Attractiveness Analysis, by Vaccine Type, 2018
  • Figure 9 : Global Human Vaccines Market Value Share Analysis, by Product, 2018 and 2027
  • Figure 10 : Global Pneumococcal Market Revenue (US$ Mn), 2017-2027
  • Figure 11 : Global Influenza Market Revenue (US$ Mn), 2017-2027
  • Figure 12 : Global Hepatitis Market Revenue (US$ Mn), 2017-2027
  • Figure 13 : Global HPV Market Revenue (US$ Mn), 2017-2027
  • Figure 14 : Global Meningococcal Market Revenue (US$ Mn), 2017-2027
  • Figure 15 : Global Rotavirus Market Revenue (US$ Mn), 2017-2027
  • Figure 16 : Global Measles and Rubella Market Revenue (US$ Mn), 2017-2027
  • Figure 17 : Global Typhoid Market Revenue (US$ Mn), 2017-2027
  • Figure 18 : Global Combination Market Revenue (US$ Mn), 2017-2027
  • Figure 19 : Global Others Market Revenue (US$ Mn), 2017-2027
  • Figure 20 : Human Vaccines Market Attractiveness Analysis, by Product, 2018
  • Figure 21 : Global Human Vaccines Market Value Share Analysis, by Distribution Channel, 2018 and 2027
  • Figure 22 : Global Hospital Pharmacies Market Revenue (US$ Mn), 2017-2027
  • Figure 23 : Global Drugstores Market Revenue (US$ Mn), 2017-2027
  • Figure 24 : Global others Market Revenue (US$ Mn), 2017-2027
  • Figure 25 : Human Vaccines Market Attractiveness Analysis, by Distribution Channel, 2018
  • Figure 26 : Global Human Vaccines Market Value Share Analysis, by Age Group, 2018 and 2027
  • Figure 27 : Global Pediatrics Market Revenue (US$ Mn), 2017-2027
  • Figure 28 : Global Adolescents Market Revenue (US$ Mn), 2017-2027
  • Figure 29 : Global Adults Market Revenue (US$ Mn), 2017-2027
  • Figure 30 : Global Geriatrics Market Revenue (US$ Mn), 2017-2027
  • Figure 31 : Human Vaccines Market Attractiveness Analysis, by Age Group, 2018
  • Figure 32 : North America Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 33 : Europe Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 34 : APAC Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 35 : Latin America Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 36 : MEA Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 37 : Global Human Vaccines Market Attractiveness Analysis, by Region
  • Figure 38 : China Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 39 : Japan Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 40 : ASEAN Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 41 : Rest of APAC Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 42 : Asia Pacific Human Vaccines Market Attractiveness Analysis, by Country
  • Figure 43 : Asia Pacific Human Vaccines Market Attractiveness Analysis, by Product
  • Figure 44 : Asia Pacific Human Vaccines Market Attractiveness Analysis, by Vaccine Type
  • Figure 45 : Asia Pacific Human Vaccines Market Attractiveness Analysis, by Age Group
  • Figure 46 : Asia Pacific Human Vaccines Market Attractiveness Analysis, by Distribution Channel
  • Figure 47 : U.S. Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 48 : Canada Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 49 : North America Human Vaccines Market Attractiveness Analysis, by Country
  • Figure 50 : North America Human Vaccines Market Attractiveness Analysis, by Product
  • Figure 51 : North America Human Vaccines Market Attractiveness Analysis, by Vaccine Type
  • Figure 52 : North America Human Vaccines Market Attractiveness Analysis, by Age Group
  • Figure 53 : North America Human Vaccines Market Attractiveness Analysis, by Distribution Channel
  • Figure 54 : Germany Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 55 : France Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 56 : U.K. Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 57 : Italy Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 58 : Spain Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 59 : Rest of Europe Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 60 : Europe Human Vaccines Market Attractiveness Analysis, by Country
  • Figure 61 : Europe Human Vaccines Market Attractiveness Analysis, by Product
  • Figure 62 : Europe Human Vaccines Market Attractiveness Analysis, by Vaccine Type
  • Figure 63 : Europe Human Vaccines Market Attractiveness Analysis, by Age Group
  • Figure 64 : Europe Human Vaccines Market Attractiveness Analysis, by Distribution Channel
  • Figure 65 : Brazil Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 66 : Mexico Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 67 : Rest of LATAM Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 68 : Latin America Human Vaccines Market Attractiveness Analysis, by Country
  • Figure 69 : Latin America Human Vaccines Market Attractiveness Analysis, by Product
  • Figure 70 : Latin America Human Vaccines Market Attractiveness Analysis, by Vaccine Type
  • Figure 71 : Latin America Human Vaccines Market Attractiveness Analysis, by Age Group
  • Figure 72 : Latin America Human Vaccines Market Attractiveness Analysis, by Distribution Channel
  • Figure 73 : GCC Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 74 : South Africa Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 75 : Rest of MEA Human Vaccines Market Size (US$ Mn) Forecast, 2019-2027
  • Figure 76 : MEA Human Vaccines Market Attractiveness Analysis, by Country
  • Figure 77 : MEA Human Vaccines Market Attractiveness Analysis, by Product
  • Figure 78 : MEA Human Vaccines Market Attractiveness Analysis, by Vaccine Type
  • Figure 79 : MEA Human Vaccines Market Attractiveness Analysis, by Age Group
  • Figure 80 : MEA Human Vaccines Market Attractiveness Analysis, by Distribution Channel
  • Figure 81 : Human Vaccine Market Share Analysis, by Company (2018

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report